NCT06992687 2025-05-28A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid TumorsShanghai Huaota Biopharmaceutical Co., Ltd.Phase 1/2 Enrolling by invitation30 enrolled